Canada markets closed

Lipocine Inc. (LPCN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
4.6800-0.0200 (-0.43%)
At close: 04:00PM EDT
4.5600 -0.12 (-2.56%)
After hours: 06:04PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
-2,851
-2,851
500
16,141
0
Cost of Revenue
10,175
10,175
8,557
7,666
9,748
Gross Profit
-13,026
-13,026
-8,057
8,475
-9,748
Operating Expenses
Research Development
7,468
-
-
-
-
Selling General and Administrative
4,905
4,905
4,062
5,330
8,248
Total Operating Expenses
4,905
4,905
4,062
5,330
8,248
Operating Income or Loss
-17,931
-17,931
-12,119
3,146
-17,996
Interest Expense
0
0
27.098
203.292
386.618
Total Other Income/Expenses Net
212.69
212.69
815.94
-3,644
-2,657
Income Before Tax
-16,351
-16,351
-10,758
-634.199
-20,965
Income Tax Expense
0.755
0.755
0.681
0.2
0.2
Income from Continuing Operations
-16,352
-16,352
-10,759
-634.399
-20,965
Net Income
-16,352
-16,352
-10,759
-634.399
-20,965
Net Income available to common shareholders
-16,352
-16,352
-10,759
-634.399
-20,965
Basic EPS
-3.09
-
-2.06
-0.17
-6.46
Diluted EPS
-3.21
-
-2.15
-0.17
-6.46
Basic Average Shares
5,221
-
5,232
5,114
3,276
Diluted Average Shares
5,223
-
5,256
5,114
3,276